Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,588 | 73,441 | 64,941 | 36,810 | 20,786 |
| Marketable Securities | 49,466 | N/A | N/A | N/A | N/A |
| Receivables | 54,120 | 47,663 | 45,357 | 44,361 | 44,350 |
| Inventories | 38,308 | 37,686 | 13,696 | 7,489 | 11,712 |
| TOTAL | $202,549 | $171,062 | $132,262 | $103,498 | $94,254 |
| Non-Current Assets | |||||
| PPE Net | 586 | 770 | 744 | 1,527 | 2,437 |
| Intangibles | 80,471 | 111,332 | 197,996 | 216,054 | 200,082 |
| Other Non-Current Assets | 1,126 | 3,255 | 82,911 | 5,468 | 6,501 |
| TOTAL | $82,183 | $115,357 | $281,651 | $223,049 | $209,020 |
| Total Assets | $284,732 | $286,419 | $413,913 | $326,547 | $303,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 470 | 12,174 | 11,942 |
| Accounts payable and accrued liabilities | 14,736 | 13,439 | 5,991 | 6,685 | 14,808 |
| Accrued Expenses | 95,151 | 76,350 | 61,607 | 67,361 | 91,978 |
| Other current liabilities | 4,801 | 3,654 | 27,248 | 48,799 | 13,958 |
| TOTAL | $114,688 | $93,443 | $95,316 | $135,019 | $132,686 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,813 | 38,514 | 66,403 | 61,319 | 72,160 |
| Other Non-Current Liabilities | 10,150 | 16,459 | 26,469 | 27,795 | 42,914 |
| TOTAL | $48,963 | $54,973 | $92,872 | $89,114 | $115,074 |
| Total Liabilities | $163,651 | $148,416 | $188,188 | $224,133 | $247,760 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,773 | 94,996 | 55,579 | 45,332 | 43,359 |
| Common Shares | 9 | 9 | 5 | 4 | 3 |
| Retained earnings | -673,124 | -651,543 | -319,601 | -429,226 | -427,945 |
| TOTAL | $121,081 | $138,003 | $225,725 | $102,414 | $55,514 |
| Total Liabilities And Equity | $284,732 | $286,419 | $413,913 | $326,547 | $303,274 |